Sarasota Interventional Radiology (SIR-Florida) has established itself as a state-of-the art facility that features the latest in technology to diagnose and treat a wide range of conditions. The expertise and leadership of leading interventional radiologist Gerald E. Grubbs, MD, SIR-Florida’s medical director, are unparalleled. Combined with board-certified anesthesiologists and a team of experienced clinical staff, SIR-Florida has built a strong reputation for delivering patient care of the highest quality on the suncoast of Florida.
One of SIR-Florida’s specialties is diagnosis and treatment of liver cancer, a cancer that originates in the organ itself. If a cancer originates in another part of the body and spreads (metastasizes) to the liver, it is not known as liver cancer but is referred to by the organ of origin. There are several types of liver cancer, the most common being hepatocellular carcinoma (HCC). The incidence of HCC has been rising since the turn of the century and is now one of the leading causes of death by cancer in the U.S.
HCC is prevalent in individuals with chronic liver diseases, e.g., cirrhosis from excessive alcohol consumption and hepatitis B or hepatitis C infection. HCC also occurs in those who have a large amount of fat in the liver, a condition known as nonalcoholic fatty liver disease. Other risk factors for liver cancer include diabetes, exposure to certain poisons known as alfatoxins and inherited liver diseases such as hemochromatosis and Wilson's disease.